Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705286 · ClinicalTrials.gov registry record · Phase 2
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia
A Phase 2 study of Ventilator Acquired Pneumonia, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,074
- Enrollment target
- 1
- Study location
NCT03705286: Completed Phase 2 study of Ventilator Acquired Pneumonia, sponsored by Yale University.
NCT03705286 is a Phase 2 study of Ventilator Acquired Pneumonia that has completed, run by Yale University. The registered enrollment target is 1,074 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (708% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03705286, a Phase 2 study of Ventilator Acquired Pneumonia, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,074 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are looking at two different types of breathing tubes to see if one is better than the other at preventing pneumonia. One of the tubes has a design features to prevent leakage of fluids from the mouth and the back of the throat into the lower airways and lungs. This is important since leakage of small amounts of fluid into the lungs may lead to pneumonia. The other tube is the standard tube used at most hospitals. The hypothesis is that the use of a breathing tube that reduces fluid leakage into the lungs will reduce the risk of developing pneumonia and improve quality of life and cognitive function, compared to the standard tube. The study will also look at the safety of the modified breathing tube, compared to the standard tube.
Primary Outcome
Physical Component Score and Mental Component Score each have scores that range from 0 - 100; Lower scores = more disability, higher scores = less disability.
Conditions Studied
Interventions
- DEVICE EVAC-PU-ETT
- DEVICE PVC-ETT
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,074 participants |
| Start Date | 2019-05-06 |
| Est. Completion | 2023-02-23 |
| Phase | Phase 2 |
What the finished NCT03705286 record still lists
NCT03705286 is an interventional study that assigns participants to a tested intervention. Its 1,074 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (708% higher).
The record links to 1 condition, with Ventilator Acquired Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which EVAC-PU-ETT is the first listed.
NCT03705286 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03705286 about?
NCT03705286 is a clinical study titled "Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia". Researchers are looking at two different types of breathing tubes to see if one is better than the other at preventing pneumonia. One of the tubes has a design features to prevent leakage of fluids from the mouth and the back of the throat into the lower airways and lungs. This is important since le...
What is the current status of trial NCT03705286?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,074 participants. The study started on 2019-05-06. Estimated completion is 2023-02-23.
What conditions does trial NCT03705286 study?
This clinical trial studies the following conditions: Ventilator Acquired Pneumonia.
What interventions are being tested in trial NCT03705286?
The interventions under investigation include: EVAC-PU-ETT (DEVICE), PVC-ETT (DEVICE).
Who is sponsoring clinical trial NCT03705286?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03705286 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilator Acquired Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03705286's enrollment target sits among peer trials
1,074 23rd of 2000 higher than 1,977 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06751043 · 1,072 participants · NA
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI